Hippocampal alterations in glutamatergic signaling during amyloid progression in AβPP/PS1 mice

Cummings, J. L., Morstorf, T. & Zhong, K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers. Res. Ther. 6, 37 (2014).

PubMed 
PubMed Central 

Google Scholar 

Godyń, J., Jończyk, J., Panek, D. & Barbara, M. Therapeutic strategies for Alzheimer’s disease in clinical trials. Pharmacol. Rep. 68, 127–138 (2016).

PubMed 

Google Scholar 

Jack, C. R. et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet. Neurol. 12, 207–216 (2013).

CAS 
PubMed 
PubMed Central 

Google Scholar 

Hyman, B. T. et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s…